NCT02494297View on ClinicalTrials.gov

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

CompletedOBSERVATIONAL
Enrollment

1,597

Participants

Timeline

Start Date

March 6, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
HirsutismAndrogenetic AlopeciaSevere AnemiaSeborrheaPCOS
Trial Locations (1)

10115

Center of Epidemiology and Health Research, Berlin

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT02494297 - DUS on the Prescribing Indications for CPA/EE in 5 European Countries | Biotech Hunter | Biotech Hunter